Health Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Globe News Wire Jun 2, 2023 CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (“Cyclerion” or the “Company”) (Nasdaq: CYCN) today announced that it has received a formal notice from The Nasdaq Stock Market (Nasdaq) stating that…
Health Cyclerion Announces Reverse Stock Split Globe News Wire May 15, 2023 CAMBRIDGE, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- Cyclerion…
Health Cyclerion Announces Corporate Updates and Q1 2023 Financial Globe News Wire May 12, 2023 Definitive agreement reached with new company (“NewCo”)…
Health Cyclerion Announces Definitive Agreement for Zagociguat and Globe News Wire May 12, 2023 Certain Cyclerion shareholders and new investors have agreed to…
Health Cyclerion Reports Corporate Update and Full Year 2022 Globe News Wire Mar 23, 2023 CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Cyclerion…